Regencell (RGC) Completes 38-for-1 Stock Split

Regencell Bioscience Holdings Limited (NASDAQ:RGC) is one of the 12 Best Performing Stocks in the Last 6 Months. On June 17, Regencell Bioscience Holdings Limited (NASDAQ:RGC) announced that it had carried out a 38-for-1 forward stock split.

For every share held on the record date, investors received 37 additional shares as a stock bonus. This stock split was announced on June 2.

Regencell (RGC) Completes 38-for-1 Stock Split

A medical laboratory surrounded by advanced equipment, symbolizing the company’s cutting-edge innovation in healthcare.

Regencell Bioscience Holdings Limited (NASDAQ:RGC) pointed out that this stock split is aimed at improving liquidity in the market for the company’s ordinary shares and making the shares more accessible to investors.

In the past 6 months, Regencell Bioscience Holdings Limited (NASDAQ:RGC) has gone up dramatically, surging by more than 13,000% as of July 29.

The rally can be attributed in part to the completion of the stock split by Regencell Bioscience Holdings Limited (NASDAQ:RGC), which helped push the stock price higher.

Regencell Bioscience Holdings Limited (NASDAQ:RGC) is a Hong Kong-based bioscience company focused on researching, developing, and commercializing traditional Chinese medicine (TCM) for the treatment of attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD).

READ NEXT: 10 Best American Semiconductor Stocks to Buy Now and 11 Best Fintech Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.